Core Viewpoint - Baiyang Pharmaceutical (301015.SZ) aims to optimize its industrial layout and seize strategic cooperation opportunities by establishing the Suzhou Baiyang Equity Investment Fund Partnership, leveraging the resources and expertise of professional investment institutions [1] Group 1: Fund Establishment - The company plans to jointly invest with several partners, including Suzhou Baiyang Feifan Enterprise Management Co., Ltd., Suzhou Guofa Asset Management Co., Ltd., and others to set up the Suzhou Baiyang Fund [1] - The fund's total subscribed capital is set at RMB 100 million, with the company contributing RMB 43 million, representing 43% of the total investment [1] Group 2: Investment Focus - The investment focus of the Suzhou Baiyang Fund will be on early-stage entrepreneurial companies in the biopharmaceutical and health sectors, particularly those with breakthrough technologies, disruptive medical devices, and proprietary intellectual property that fill domestic gaps [1] - The geographical investment concentration will be in the Suzhou Industrial Park [1]
百洋医药：拟与专业投资机构共同投资基金